Table 1.
PBD | ||||
---|---|---|---|---|
N | No (n=73) | Yes (n=84) | p-Value | |
Patient Demographics | ||||
Age at MDT Assessment (Years) | 157 | 66.2 ± 8.7 | 68.9 ± 9.7 | 0.075 |
Gender (% Male) | 157 | 36 (49%) | 47 (56%) | 0.427 |
BMI | 152 | 26.7 ± 4.9 | 27.4 ± 5.5 | 0.152 |
CCI | 157 | 0.199* | ||
2-3 | 14 (19%) | 15 (18%) | ||
4-5 | 41 (56%) | 38 (45%) | ||
6+ | 18 (25%) | 31 (37%) | ||
Smoking Status | 157 | 0.286 | ||
No | 60 (82%) | 71 (85%) | ||
Current | 10 (14%) | 6 (7%) | ||
Ex | 3 (4%) | 7 (8%) | ||
CA19-9 (U/ml) | 135 | 307 (116–959) | 318 (92–1718) | 0.643 |
Surgery | 157 | 73 (100%) | 61 (73%) | <0.001 |
Surgical Factors | ||||
Days from Diagnosis to Surgery** | 134 | 14 (10–21) | 59 (45–77) | <0.001 |
Bilirubin (at Surgery, µmol/L)** | 133 | 307 (222–411) | 15 (8–61) | <0.001 |
Type of Surgery** | 134 | <0.001 | ||
Resection | 71 (97%) | 45 (74%) | ||
Bypass | 2 (3%) | 16 (26%) | ||
Vein Reconstruction*** | 116 | 20 (28%) | 8 (18%) | 0.292 |
T-Stage*** | 116 | 0.496* | ||
T1 | 13 (18%) | 9 (20%) | ||
T2 | 55 (77%) | 30 (67%) | ||
T3 | 3 (4%) | 6 (13%) | ||
N-Stage*** | 116 | 0.547* | ||
N0 | 9 (13%) | 4 (9%) | ||
N1 | 32 (45%) | 20 (44%) | ||
N2 | 30 (42%) | 21 (47%) | ||
Overall Stage*** | 116 | 0.468* | ||
1 | 8 (11%) | 3 (7%) | ||
2 | 32 (45%) | 20 (44%) | ||
3 | 31 (44%) | 22 (49%) | ||
R-Status (% R1)*** | 116 | 29 (41%) | 17 (38%) | 0.846 |
LN ratio*** | 116 | 0.19 (0.07–0.36) | 0.21 (0.06–0.33) | 0.966 |
Patient demographics are reported for the cohort as a whole, while surgical factors are reported only for the subgroup who underwent surgery (N=73/61 for PBD No/Yes), and tumor staging and resection-related factors for the subgroup that underwent resection (N=71/45). Continuous data are reported as mean ± SD, or as median (interquartile range), with p-values from Mann-Whitney U tests. Categorical data are reported as N (%), with p-values from Fisher’s exact tests or Chi-square. Bold p-values are significant at p<0.05. *p-Value from a Mann-Whitney U test, as the factor is ordinal. **In patients undergoing surgery; time is from initial CT scan. ***In patients undergoing resection.
MDT, multidisciplinary team; BMI, body mass index; CCI, Charlson Comorbidity Index; LN ratio, lymph node ratio.